2026 Elections to the BOPA Executive Committee: Call for nomination of members

BOPA is looking for new Executive Committee members who are dedicated to furthering the association’s aims and who are willing, and able, to spend time helping run the organisation. Those elected will be involved in working on and supporting the BOPA Vision and Strategy, contributing to national objectives and workstreams, advocating for Cancer Pharmacy, supporting our subcommittees and be part of arranging the highly regarded annual conference – plus much more!

The Executive Committee work as a team, supporting each other on behalf of our members and our patients.  The committee has a streamlined format to fit in with busy work schedules for its regular meetings, consisting of a 2-hour tele-conference call once every month, with up to a maximum of two face-to-face meetings during the year.  You will be expected to attend a minimum of 50% of committee meetings every year, and everyone will be expected to lead on a project from our work plan.  It is also an expectation that BOPA related work will take up approximately 1-2 hours/week in addition to the scheduled meetings – it is important that you can commit to this work load.

This is a really exciting opportunity to shape the BOPA Vision and Strategy as well as giving you great experience of working at a national level and building links and relationships with colleagues from across the UK.

Please note: In October 2024, BOPA membership has voted to become a Charity Incorporated Organisation (CIO). As part of the new Charity Constitution, all elected Executive Members from AGM 2026 will become Charity Trustees of the BOPA Charity. Charity Trustees are required to register with the Charity Commission, and are legally responsible for the running of BOPA. Please read the following link to understand what being a trustee (executive member) involves: Charity trustee: what’s involved

This year we are looking for the following positions to fill:

  • Standard Committee Member (6 places available)

Three standard committee members, Shereen Nabhani-Gebara (BOPA Chair), Michal Sladkowski (BOPA Vice Chair-Elect) and Clayton Wong (BOPA Secretary and Treasurer-Elect), are also approaching their end of term in office. The Executive Committee have voted to activate Clause 9b of the BOPA constitution and extend their terms by one-year in order to ensure smooth transition of the roles of Executive Officers within the organisation. The election of their standard committee places will therefore be deferred for one-year.

Applicants must be pharmacists or pharmacy technicians in the practice of cancer pharmacy, on the current register of the General Pharmaceutical Council (or registered with an equivalent organisation e.g. overseas), and be current BOPA paid members.

Please note that BOPA cannot offer remuneration to committee members, but travel expenses are reimbursed.

An electronic nomination form is available here. Forms must be submitted by 23:59 on 31st July 2026. Nominations require the support of two additional BOPA members.

If you wish to find out more about what being a committee member entails, please feel free to contact any of the current members of the committee. They can be contacted through the website (https://www.bopa.org.uk/contact/) or email [email protected]

Nomination Form Here

Latest News

By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article